Ligand discloses private placement investment in Athira Pharma

LIGAND PHARMACEUTICALS INC

Private placement investment in Athira Pharma, Inc. announced via social media and IR page.
No financial terms, size, or pricing disclosed in the 8-K filing.
Ligand directs investors to its website and social media for further details.

item 7.01

LIGAND PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001193125-25-324830

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.